UTI in pregnancy

武功密笈

小黃藏書

OBS
GYN
Gyn Oncology
Infertility
Urogynecology

首頁 向上 Urinary Incontinence Urogynecologic Sono Pelvic Organ Prolapse Bladder Disorder UTI 婦女泌尿學 GSI acute urethral syndrome UTI in pregnancy


~ Lower UTI in Pregnancy ~

 

§ Background:

v Approximately 5% to 7% of pregnant women have asymptomatic bacteriuria

at their first prenatal visit.

v Prior colonization rather than new infection

 

§ Risk factors:

? Socioeconomic status

Sickle cell disease

ƒ Anatomic abnormalities of the urinary system

Conditions associated with neurogenic urinary retention, such as spinal cord

injuries or multiple sclerosis

Diabetes

A history or UTI

Pregnancy itself, secondary to the urostasis effect of progesterone and the

obstructive effect of the gravid uterus

 

§ Clinical manifestations:

v Asymptomatic bacteriuria predisposes pregnant patients to pyelonephritis and

potential complications such as sepsis, renal dysfunction, and preterm labor

with all its sequelae for the newborn.

v Without treatment, up to 50% of these women will develop symptomatic

UTI ? that is, pyelonephritis ? during the pregnancy.

v Recurrence of bacteriuria occurs in 10% to 40% of pregnant women treated

for bacteriuria.

 

§ Pathology and etiology:

v Gram-negative rods: 90%

- Escherichia coli (the most common organism isolated)

- Klebsiella sp, Enterobacter sp, and Proteus sp.

v Others: Group B streptococci and Staphylococcus saprophyticus

 

§ Diagnosis:

v Culture and susceptibility testing are the standard means of diagnosing and

managing UTI during pregnancy.

ø Definition of bacteriuria:

- for first-void midstream clean-catch urine specimens:

Presence of more than 105 CFU/mL from two consecutive specimens

- for a non-first-void specimens:

Presence of more than 102 CFU/mL of a single pathogen

v Nonculture testing:

Leukocyte esterase and microbe-produced nitrites by urine dipstick

v Testing for Neisseria gonorrhoeae and Chlamydia trachomatis

 

§ Treatment:

 

Indication

Regimen

Trimethoprim/sulfamethoxazole

(BaktarR) (80/400)

2# bid

7-10 days, except

near term

Nitrofurantoin

(MacrodantinR) (100)

0.5-1# q6-8h

7-10 days

Amoxicillin (250)

2# q8h

7-10 days

Cephalexin

(KeflexR) (250, 500)

250-500 mg

q6h

7-10 days

Nitrofurantoin

(MacrodantinR) (100)

0.5-1# qd, or

0.5# bid

Cephalexin

(KeflexR) (250, 500)

250-500 mg bid

ø Sulfonamides:

- Used with caution close to delivery because of their potential for

displacing fetal bilirubin and inducing kernicteris.

- May produce fetal hemolytic anemia in G6PD deficiency.

ø Nitrofurantoin:

- May produce fetal hemolytic anemia in G6PD deficiency.

- Very effective

ø Quinolones should be avoided in pregnancy.

ø Cephalosporins;

- Should not be use for single-dose treatment owing to high failure rate

(40%)

ø Regardless of the regimen, a follow-up test of cure is mandatory.

 

 

§ Conclusion:

Asymptomatic bacteriuria in a pregnant patient can cause pyelonephritis

and complications such as sepsis, renal dysfunction, and preterm labor.

Appropriate screening and management prevents such adverse outcomes.

 

§ References:

1. Lower urinary tract infections in pregnancy. S. Gene McNeeley, Jr., MD, and David C. Kmak,

MD. Contemporary OB/GYN Jan. 2000: 15-19

Filename: Lower UTI in Pregnancy